Lymphoplasmacytic Lymphoma Completed Phase 2 Trials for Imexon (DB05003)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0031072 (Lymphoplasmacytic Lymphoma) | Completed | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01314014 | Imexon for Relapsed Follicular and Aggressive Lymphomas | Treatment |